South Korea could soon have at least one homegrown vaccine for the coronavirus with the government announcing a boost to investment in the sector.
The government said Thursday that it's going to inject more than 4-hundred-44 million dollars next year into developing vaccines and treatments twice the amount this year.
The goal is part of an ambitious plan to make South Korea a global hub for COVID-19 vaccines with a budget of over 1.9 billion U.S. dollars over the next five years.
Currently, SK Bioscience is in phase three clinical trials of its vaccine candidate, with commercialization expected as early as the first half of next year.
It's one of eight local companies with vaccines in the works.